Merck stock up 11% YTD as Keytruda growth, pipeline gains and M&A lift outlook, but patent risks, Gardasil slump and generics weigh on near-term upside.

Merck (MRK) closed at $117.10 in the latest trading session, marking a -1.65% move from the prior day. The stock fell short ...

A bullish diagonal spread is an advanced option trade and generally not suitable for beginners, but it can have its place ...

Over the past six months, Merck has been a great trade, beating the S&P 500 by 32%. Its stock price has climbed to $118.94, ...

On April 13, UBS analyst Michael Yee lifted the firm’s price recommendation on Merck & Co., Inc. (NYSE:MRK) to $145 from $130 ...

Merck (NYSE: MRK) has taken its shareholders on a wild ride of late -- from last March's record high of more than $130 to this May's low near $76 back to its current price of just a little more than ...

Merck (NYSE: MRK) rose after six straight sessions of losses, with shares up 2.17% at $117.97 on Friday afternoon. Over the prior six sessions, the stock had fallen 6.27%, underperforming a 3.81% gain ...

Two stocks retirement investors typically reach for in uncertain markets have risen notably in recent months. Is it too late to buy?

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Consistent Dividend Stocks to Buy Right Now. On April 6, JPMorgan ...

Merck’s MRK stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, indicating sustained bullish momentum. The 50-day moving average is a short-term ...

Merck & Co., Inc. (NYSE:MRK) is included among the 12 High Dividend Stocks Picked by Billionaire Ray Dalio. On April 17, ...

Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning drug. The trading crowd changed its collective mind a couple months ago, sending ...